Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Maitake mushroom (Grifola frondosa) has been studied for its potential effects on components of Metabolic Syndrome, including glucose metabolism, insulin sensitivity, and lipid profiles. Preclinical studies, primarily in animal models, suggest that extracts from maitake can lower blood glucose and improve insulin resistance, possibly due to its polysaccharide fraction, especially the D-fraction beta-glucan. Some small-scale human studies have reported modest improvements in blood glucose and lipid parameters, but these trials are generally limited by small sample size, short duration, and lack of rigorous controls.

Mechanistically, maitake mushroom may exert its metabolic effects by modulating immune function, reducing inflammation, and influencing the secretion or action of insulin and adipokines. Traditionally, maitake has been used in East Asian medicine for general health and vitality, but its specific use for “metabolic syndrome” is a more recent development based on evolving scientific interest in functional foods.

Overall, while there is preliminary scientific evidence supporting a potential benefit of maitake mushroom in managing certain aspects of metabolic syndrome, the clinical evidence remains limited and inconclusive. Larger, well-designed human trials are needed to confirm efficacy and safety. Therefore, the use of maitake for metabolic syndrome is best described as supported by early-stage scientific research rather than strong clinical validation.

More about maitake mushroom
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by maitake mushroom

Products containing maitake mushroom

Nature's Sunshine Estro-Assured (Formerly Breast Assured)
Nature's Sunshine Colostrum (With Immune Factors)
Nature's Sunshine Immune System
Nature's Sunshine Immune Stimulator